What it is (overview)

MRI Spectroscopy (also called Magnetic Resonance Spectroscopy or MRS) is a specialized type of MRI that looks beyond anatomy (what tissues look like) and measures the biochemical composition of tissue (what tissues are made of). It is a non-invasive imaging test that uses the same MRI machine and magnetic fields, but it analyzes chemical “signals” from certain molecules inside a targeted area—most commonly the brain, but sometimes other tissues as well.

Instead of producing only pictures, MRI spectroscopy generates a “spectrum” (a graph) that reflects the relative amounts of specific chemicals (metabolites) in the tissue being studied. Commonly evaluated metabolites include:

• N-acetylaspartate (NAA): often associated with healthy nerve cells; lower levels can suggest neuronal injury or loss.
• Choline: associated with cell membrane turnover; higher levels can be seen with many tumors and active tissue growth or inflammation.
• Creatine: related to energy metabolism; often used as a reference point.
• Lactate: can rise when tissue is under low oxygen conditions or in some tumors/infections.
• Myo-inositol: can be elevated in certain neurological conditions and gliosis (a type of scarring response in the brain).

In plain language, MRI spectroscopy helps your doctor understand whether tissue changes seen on an MRI are more likely due to things like a tumor, treatment effects, inflammation, infection, reduced blood/oxygen supply, or other metabolic disorders. Results are interpreted by a radiologist in the context of your symptoms, exam, and other tests. It usually does not provide a single “positive/negative” answer on its own, but it can add important clarity to a diagnosis and guide next steps.

When & why it's usually done

Doctors typically order MRI spectroscopy when they need more information than a standard MRI can provide—especially when the MRI shows an abnormal area and the cause is not clear. Because it performs tissue analysis at a chemical level, it can help assess how active or aggressive a process may be and whether changes are improving or worsening over time.

Common reasons MRI spectroscopy may be recommended include:

• Evaluating a brain mass or suspected tumor: to help distinguish tumor types and grades, assess tumor activity, and identify areas that may be best for biopsy planning.
• Clarifying an unclear MRI finding: when a lesion could represent tumor, inflammation, infection, demyelination, or scarring.
• Monitoring known tumors: to help differentiate tumor recurrence from treatment-related changes such as radiation necrosis or pseudoprogression.
• Assessing neurological symptoms with unexplained imaging findings, such as persistent headaches, seizures, new weakness/numbness, vision or speech changes, dizziness, cognitive changes, or memory problems.
• Investigating metabolic disorders or suspected abnormalities in tissue metabolism, particularly in complex or atypical neurological cases.
• Evaluating infection or inflammation in the brain when clinical signs and routine imaging are not definitive.

Your clinician may also choose MRI spectroscopy to reduce uncertainty before recommending invasive procedures (like biopsy) or to help tailor a treatment plan. Like a standard MRI, this test requires you to lie still in the scanner; it may be performed with or without contrast depending on the clinical question.

Common diseases related to it

• Brain tumors (e.g., gliomas such as astrocytoma, oligodendroglioma, glioblastoma)
• Metastatic brain tumors (cancer spread to the brain)
• Primary central nervous system lymphoma (PCNSL)
• Tumor recurrence vs radiation necrosis after treatment
• Multiple sclerosis and other demyelinating diseases
• Stroke and ischemic brain injury
• Brain infections (e.g., abscess; certain encephalitides may have characteristic patterns)
• Traumatic brain injury (selected cases)
• Neurodegenerative conditions where metabolic changes support evaluation (e.g., some dementias, depending on protocol and clinical use)
• Selected metabolic and mitochondrial disorders affecting the brain

Health goals where it may help

• Supporting early and accurate diagnosis when MRI findings are uncertain, especially for brain and nervous system conditions
• Guiding treatment planning for tumors (e.g., helping target the most active area for biopsy or monitoring response)
• Monitoring brain health over time by tracking metabolic changes during or after therapy
• Distinguishing active disease from healing/scar tissue (for example, recurrence vs treatment effect)
• Reducing the need for invasive testing in some situations by adding non-invasive biochemical information
• Evaluating tissue metabolism to better understand symptoms such as seizures, cognitive changes, or persistent headaches when standard imaging is not definitive